The primary endpoint was myocardial infarct size as assessed by cardiac biomarkers, troponin (cTnI) and creatine kinase (CK). Oxygen therapy was commenced by paramedics, and continued for up to 12 h ...

One hundred and four patients (67%) were male. Elevated cTnI levels were found in 30 (19%) patients (Group B). One hundred and twenty-six (81%) patients had normal cTnI levels (Group A).

The optimal threshold for defining prognostically relevant periprocedural myocardial injury (PMI) in patients with NSTEMI was found to be a post-PCI change in cardiac troponin I (cTnI) of >40%, along ...

Intracoronary provocation testing with acetylcholine (ACh) is helpful to diagnose and risk‐stratify patients with ischemia with nonobstructed coronary arteries (NOCA) and myocardial infarction with ...

Each monthly podcast delivers a quick update on key highlights from the journal’s current issue and expert insights into new research that will have an impact in the field.

The cTnI, TNF-α, and IL-1β kits were obtained from Xinbosheng Bioengineering (Shenzhen, China). Bicinchoninic acid (BCA) reagent was obtained from Generay Biotechnology (Shanghai, China). All other ...

The serum contents of cTnI were determined using a rat cTnI ELISA Kit (Andihuatai Technology Co. Ltd., Beijing, China) and detected by microplate reader (MULTISKAN MK3; Thermo, San Jose, CA, USA).